 IRVINE, CA ACCESSWIRE March 5, 2020 Hancock Jaffe Laboratories, Inc. Nasdaq:HJLI, HJLIW, a developer of medical devices that restore cardiac and vascular health, announced today that Dr. Jorge Hernando Ulloa, the Principal Investigator for HJLIs first-in-man VenoValve study in Colombia, presented new VenoValve data at the 32nd Annual Meeting of the American Venous Forum AVF at the Omni Amelia Island Plantation Hotel at Amelia Island, Florida. Dr. Ulloas presentation included data on 8 VenoValve patients that are six months post VenoValve surgery including one patient that is one year post surgery, 2 patients that are 90 days post-surgery, and 1 patient that is 60 days post-surgery. 